Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sebastian Lapman"'
Autor:
Sebastian Lapman, Ben Sprangers
Publikováno v:
Clinical Kidney Journal
Ifosfamide is a commonly used chemotherapeutic known to have numerous adverse kidney manifestations. In this issue of Clinical Kidney Journal, Ensergueix et al. report a multicentric observational retrospective French study on 34 adult patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebe9dd17de59447503b9c79e700cd079
https://doi.org/10.1093/ckj/sfaa017
https://doi.org/10.1093/ckj/sfaa017
Autor:
Yuriy Khanin, Vanesa Bijol, Rushang Parikh, Kenar D. Jhaveri, William L. Whittier, Sebastian Lapman, Rimda Wanchoo
Publikováno v:
Journal of Onco-Nephrology. 4:52-58
Immune checkpoint inhibitors are a cornerstone in the management of many oncological disorders, and their indications continue to grow. However, as with any therapy we must remain vigilant of the possible adverse effects. Although interstitial nephri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b3d400b0ba5b8bb1a5f4879da77f40e
https://doi.org/10.1177/2399369320907598
https://doi.org/10.1177/2399369320907598
Autor:
Simoni Khashu, Nitya Wanchoo, Kayla D Finuf, Sebastian Lapman, Prakash Gudsoorkar, Kenar D Jhaveri
Publikováno v:
Clinical kidney journal. 15(4)
Graphical Abstract.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3100cb7785793710da9d43deb0ad89cf
https://pubmed.ncbi.nlm.nih.gov/35371468
https://pubmed.ncbi.nlm.nih.gov/35371468